Document is current
Any future updates will be listed below
-
Authors
Heylen, Elien https://orcid.org/0000-0002-8102-3209
Verstraete, Paulien
Van Aerschot, Linde
Geeraerts, Shauni L.
Venken, Tom https://orcid.org/0000-0003-0773-1810
Timcheva, Kalina
Nittner, David
Verbeeck, Jelle
Royaert, Jonathan
Gijbels, Marion
Uyttebroeck, Anne
Segers, Heidi https://orcid.org/0000-0002-3604-7850
Lambrechts, Diether https://orcid.org/0000-0002-3429-302X
Cools, Jan
De Keersmaecker, Kim https://orcid.org/0000-0002-7420-9531
Kampen, Kim R. https://orcid.org/0000-0001-5065-1272
-
Funding
Funding for this research was provided by:
Fonds Wetenschappelijk Onderzoek (1106121N, 1116822N, 1S14517N, G0A4220N, KAN2018 1501419N)
Kom op tegen kanker (Stand up to Cancer), the Flemish cancer society (projectID: 13035).
Stichting Tegen Kanker (project F/2020/1333, project F/2020/1333)
KU Leuven (C14/18/104)
KWF Kankerbestrijding (#13486)
- License Information
-
More Information
Article History
Received: 16 January 2023
Revised: 10 February 2023
Accepted: 21 February 2023
First Online: 17 March 2023
Competing interests
: The authors declare no competing interests.
: Experiments on human samples were approved and supervised by the UZ Leuven ethical committee. Informed consent was obtained from all subjects. Peripheral blood samples obtained at diagnosis were collected from children diagnosed with T-ALL at University Hospital Leuven, as approved by the local Ethical Committee (S54608).
: Not applicable.
